Puretech Health PLC — RNS

Regulatory news across PRTC

Date	Time	Date	TitleTitle (filtered)	Source
18/03/19	07:00:05	18 Mar 2019	Karuna Announces $68 Million Series B Financing	Karuna Announces $68 Million Series B Financing	RNS
15/03/19	07:00:06	15 Mar 2019	Notice of Results	Notice of Results	RNS
07/03/19	07:00:17	7 Mar 2019	Akili & Shionogi Deal in Taiwan/Japan $20M upfront	Akili & Shionogi Deal in Taiwan/Japan $20M upfront	RNS
05/03/19	07:00:30	5 Mar 2019	Karuna Appoints Chief Financial Officer	Karuna Appoints Chief Financial Officer	RNS
22/02/19	16:41:17	22 Feb 2019	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
22/02/19	16:36:10	22 Feb 2019	Price Monitoring Extension	Price Monitoring Extension	RNS
21/02/19	07:00:21	21 Feb 2019	PRTC to Present at Two US Investor Conferences	PRTC to Present at Two US Investor Conferences	RNS
15/02/19	16:41:11	15 Feb 2019	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
15/02/19	16:35:36	15 Feb 2019	Price Monitoring Extension	Price Monitoring Extension	RNS
14/02/19	07:00:07	14 Feb 2019	Vor Raises $42M to Advance Leukaemia Treatment	Vor Raises $42M to Advance Leukaemia Treatment	RNS
28/01/19	07:00:07	28 Jan 2019	Alivio Partners to Advance Non-opioid Pain Therapy	Alivio Partners to Advance Non-opioid Pain Therapy	RNS
23/01/19	18:08:47	23 Jan 2019	Vedanta Immuno-oncology Candidate Published	Vedanta Immuno-oncology Candidate Published	RNS
02/01/19	07:00:06	2 Jan 2019	Total Voting Rights	Total Voting Rights	RNS
28/12/18	12:07:57	28 Dec 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
28/12/18	12:02:36	28 Dec 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
24/12/18	07:00:05	24 Dec 2018	Vedanta Biosciences Raise $27M Series C Financing	Vedanta Biosciences Raise $27M Series C Financing	RNS
17/12/18	07:00:06	17 Dec 2018	Vedanta Initiates Phase 2 Study for Lead Candidate	Vedanta Initiates Phase 2 Study for Lead Candidate	RNS
10/12/18	07:00:06	10 Dec 2018	Vedanta & BMS Immuno-Oncology Collaboration	Vedanta & BMS Immuno-Oncology Collaboration	RNS
28/11/18	07:00:08	28 Nov 2018	Vor Granted First-in-class Immuno-oncology Patent	Vor Granted First-in-class Immuno-oncology Patent	RNS
27/11/18	07:00:22	27 Nov 2018	Janssen/Vedanta Phase 1 in IBD & $12M Milestone	Janssen/Vedanta Phase 1 in IBD & $12M Milestone	RNS
26/11/18	16:40:36	26 Nov 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
26/11/18	16:35:28	26 Nov 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
22/11/18	12:07:47	22 Nov 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
22/11/18	12:02:32	22 Nov 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
16/11/18	12:07:40	16 Nov 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
16/11/18	12:02:39	16 Nov 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
14/11/18	12:07:53	14 Nov 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
14/11/18	12:02:29	14 Nov 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
13/11/18	11:05:53	13 Nov 2018	Full Gelesis Data Published in the Journal Obesity	Full Gelesis Data Published in the Journal Obesity	RNS
07/11/18	07:00:05	7 Nov 2018	PRTC to Present at Jefferies 2018 in London	PRTC to Present at Jefferies 2018 in London	RNS
06/11/18	13:00:02	6 Nov 2018	Vedanta Presents Data on Immuno-Oncology Candidate	Vedanta Presents Data on Immuno-Oncology Candidate	RNS
05/11/18	07:00:07	5 Nov 2018	Gelesis to Present Full Data for Lead Candidate	Gelesis to Present Full Data for Lead Candidate	RNS
31/10/18	12:07:50	31 Oct 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
31/10/18	12:02:34	31 Oct 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
26/10/18	17:41:02	26 Oct 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
26/10/18	17:35:51	26 Oct 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
17/10/18	08:00:05	17 Oct 2018	Karuna Adds Sage Therapeutics CEO to Board	Karuna Adds Sage Therapeutics CEO to Board	RNS
15/10/18	08:00:05	15 Oct 2018	Karuna Initiates Phase 2 Study in Schizophrenia	Karuna Initiates Phase 2 Study in Schizophrenia	RNS
04/10/18	08:00:08	4 Oct 2018	Vedanta Announces Successful Ph1 Clinical Results	Vedanta Announces Successful Ph1 Clinical Results	RNS
17/09/18	17:15:29	17 Sept 2018	Brain Lymphatics Published in Nature Neuroscience	Brain Lymphatics Published in Nature Neuroscience	RNS
12/09/18	13:00:01	12 Sept 2018	Akili Exclusively Licenses New Digital Technology	Akili Exclusively Licenses New Digital Technology	RNS
12/09/18	08:00:06	12 Sept 2018	Alivio Awarded $3.3M Grant from US Dept of Defense	Alivio Awarded $3.3M Grant from US Dept of Defense	RNS
11/09/18	08:00:14	11 Sept 2018	PureTech Health plc - Half-Year Report	PureTech Health plc - Half-Year Report	RNS
07/09/18	17:40:55	7 Sept 2018	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
07/09/18	17:35:42	7 Sept 2018	Price Monitoring Extension	Price Monitoring Extension	RNS
05/09/18	08:00:15	5 Sept 2018	Vedanta Adds Fmr Janssen Immunology Head to Board	Vedanta Adds Fmr Janssen Immunology Head to Board	RNS
29/08/18	08:00:06	29 Aug 2018	Notice of Results	Notice of Results	RNS
15/08/18	12:00:03	15 Aug 2018	PureTech's Karuna Appoints Steven Paul, MD, as CEO	PureTech's Karuna Appoints Steven Paul, MD, as CEO	RNS
09/08/18	08:01:03	9 Aug 2018	PureTech's Akili Expands Series C Funding to $68M	PureTech's Akili Expands Series C Funding to $68M	RNS
02/08/18	08:00:17	2 Aug 2018	PureTech's Karuna Completes $42M Financing	PureTech's Karuna Completes $42M Financing	RNS

Showing 951–1000 of 1,162 announcements